Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants.

Goetzman, B W; Read, L C; Plopper, C G; Tarantal, A F; George-Nascimento, C; Merritt, T A; Whitsett, J A; Styne, D

Goetzman, B W; Read, L C; Plopper, C G; Tarantal, A F; George-Nascimento, C; Merritt, T A; Whitsett, J A; Styne, D.

Affiliation

Goetzman BW; Department of Pediatrics, School of Medicine, University of California, Davis 95616.

Pediatr Res ; 35(1): 30-6, 1994 Jan.

Article in En | MEDLINE | ID: mdl-8134196

Subject(s)

Epidermal Growth Factor/administration & dosage; Fetus/drug effects; Respiratory Distress Syndrome, Newborn/prevention & control; Amniotic Fluid; Animals; Animals, Newborn; Female; Fetal Organ Maturity/drug effects; Humans; Infant, Newborn; Lung/drug effects; Lung/embryology; Lung/pathology; Macaca mulatta; Male; Peritoneal Cavity; Pregnancy; Recombinant Proteins/administration & dosage; Respiration, Artificial; Respiratory Distress Syndrome, Newborn/physiopathology; Respiratory Distress Syndrome, Newborn/therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome, Newborn / Epidermal Growth Factor / Fetus Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Female / Humans / Male / Newborn / Pregnancy Language: En Journal: Pediatr Res Year: 1994 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links